| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.42 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |